Literature DB >> 3610518

Pharmacokinetics of benzydamine.

R D Schoenwald, T Kumakura, B Catanese.   

Abstract

Benzydamine is a non-steroidal anti-inflammatory drug especially used topically for the treatment of primary or normoreactive types of inflammation. The pharmacokinetics of benzydamine are reported after both topical and systemic administration, and the available data are reviewed with particular reference to its topical use.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3610518

Source DB:  PubMed          Journal:  Int J Tissue React        ISSN: 0250-0868


  3 in total

1.  In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms.

Authors:  D H Lang; A E Rettie
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

2.  Benzydamine inhibits monocyte migration and MAPK activation induced by chemotactic agonists.

Authors:  Elena Riboldi; Giada Frascaroli; Pietro Transidico; Walter Luini; Sergio Bernasconi; Francesca Mancini; Angelo Guglielmotti; Claudio Milanese; Mario Pinza; Silvano Sozzani; Alberto Mantovani
Journal:  Br J Pharmacol       Date:  2003-08-18       Impact factor: 8.739

3.  Pharmacology of benzydamine.

Authors:  P A Quane; G G Graham; J B Ziegler
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.